Based on NIH | Is there evidence that taking turmeric or curcumin can reduce thyroid autoantibodies or improve symptoms in Hashimoto’s thyroiditis?

Turmeric/curcumin and Hashimoto’s: what the evidence shows

• There is currently no high‑quality clinical evidence that turmeric or curcumin lowers thyroid autoantibodies (anti‑TPO or anti‑thyroglobulin) or improves Hashimoto’s symptoms in people with autoimmune thyroiditis.
• Most data are laboratory or indirect, and professional guidelines do not recommend curcumin for Hashimoto’s at this time.

What Hashimoto’s involves

Hashimoto’s thyroiditis is an autoimmune condition where the immune system creates antibodies that attack the thyroid, which can eventually lead to an underactive thyroid (hypothyroidism). ^[1] This immune attack is commonly detected by measuring thyroid autoantibodies in blood tests, such as anti‑thyroid peroxidase (TPOAb) and anti‑thyroglobulin (TgAb). ^[2]

What we know about curcumin in autoimmune disease

• Laboratory (in vitro) work suggests heat‑solubilized curcumin or turmeric can block antibody–antigen binding in test tubes for several autoimmune antibodies (e.g., in Sjögren’s syndrome and lupus), but this is not a human clinical outcome and was not specific to thyroid antibodies. ^[3]
• In a small randomized crossover trial in obese adults, 1 g/day of curcuminoids reduced oxidative stress markers but did not change measured antibody levels (anti‑Hsp27 and anti‑oxLDL), suggesting antioxidant effects without clear immune‑antibody modulation in people. ^[4]
• Major cancer‑center integrative medicine reviews note that turmeric/curcumin has complex mechanisms, poor absorption, and largely preclinical data; development for clinical use needs further study. ^[5] These reviews highlight mixed findings across conditions and emphasize that evidence is preliminary. ^[6]

Evidence specifically in Hashimoto’s thyroiditis

• No randomized controlled trials were found showing that turmeric or curcumin lowers TPOAb or TgAb in Hashimoto’s thyroiditis or improves thyroid‑specific symptoms or thyroid function.
• A different nutraceutical, anatabine (not turmeric/curcumin), showed a decrease in TgAb (but not TPOAb) over 3 months versus placebo in one randomized study, underscoring that positive findings with one compound cannot be generalized to curcumin. ^[7]
• Current clinical practice guidance for subclinical hypothyroidism/autoimmune thyroiditis focuses on monitoring thyroid function and antibodies, and initiating levothyroxine when appropriate; it does not endorse curcumin as a therapy. ^[8]

Safety and practical considerations

• Turmeric/curcumin is generally well tolerated, but absorption is low; formulations vary widely, and long‑term thyroid‑specific safety/efficacy data are lacking. ^[5]
• If you take levothyroxine, the main absorption interactions are with agents like calcium/iron, bile‑acid sequestrants, sucralfate, antacids, and proton‑pump inhibitors; turmeric is not listed among known agents that reduce levothyroxine absorption in official labeling. ^{[9] [10]} It’s still wise to take thyroid hormone on an empty stomach, separate from supplements, to avoid unforeseen interactions. ^[9]
• Hashimoto’s care centers on maintaining normal thyroid hormone levels with levothyroxine and monitoring symptoms and labs; antibodies may remain positive even when thyroid function is normalized, and treatment decisions are guided by TSH/FT4 rather than antibody titers alone. ^{[1] [2]}

Bottom line

• There is no reliable clinical evidence that turmeric or curcumin reduces anti‑TPO or anti‑thyroglobulin antibodies or improves thyroid‑related outcomes in Hashimoto’s thyroiditis.
• Laboratory findings are intriguing but do not replace human trials, and guidelines do not recommend curcumin for Hashimoto’s management. ^{[5] [8]}
• If you still wish to try a curcumin supplement for general anti‑inflammatory support, consider it an adjunct, monitor your thyroid labs regularly, separate dosing from levothyroxine, and discuss with your clinician especially given variability in supplement quality and bioavailability. ^{[9] [10]}

---

Table: Summary of evidence on turmeric/curcumin for Hashimoto’s thyroiditis

• Question: Lowers thyroid antibodies (TPOAb/TgAb)?

  • Evidence: No human Hashimoto’s trials; in vitro antibody–antigen inhibition not thyroid‑specific. ^[3]

• Question: Improves hypothyroid symptoms or thyroid function?

  • Evidence: No clinical trials showing benefit in Hashimoto’s; guideline recommendations do not include curcumin. ^[8]

• Related nutraceutical comparator (not curcumin): Anatabine

  • Evidence: RCT showed reduction in TgAb but not TPOAb over 3 months. ^[7]

• Safety/Interactions with levothyroxine

  • Evidence: Turmeric not listed among agents that reduce levothyroxine absorption in labeling; still take thyroid hormone on an empty stomach, away from other supplements/meds known to interfere. ^{[9] [10]}

• Overall conclusion

  • Evidence: Insufficient to recommend turmeric/curcumin for antibody reduction or symptom improvement in Hashimoto’s; more trials needed. ^{[5] [8]}